FOURNIER LAB IRELAND LTD innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	EPO (European Patent Office)	16
#2	China	9
#3	United States	9
#4	Canada	8
#5	Norway	8
#6	Israel	7
#7	WIPO (World Intellectual Property Organization)	7
#8	Brazil	6
#9	Mexico	5
#10	Hong Kong	4
#11	EAPO (Eurasian Patent Organization)	3
#12	Morocco	3
#13	South Africa	3
#14	Argentina	2
#15	Australia	2
#16	Republic of Korea	2
#17	Bulgaria	1
#18	Czechia	1
#19	Algeria	1
#20	Estonia	1
#21	Hungary	1
#22	Ireland	1
#23	Poland	1
#24	Singapore	1
#25	Slovakia	1
#26	Tunisia	1

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Acyclic or carbocyclic compounds
#4	Unspecified technologies

Publication	Filing date	Title
BRPI0922520A2	2009-12-31	"use of fibrates"
US2008241070A1	2008-03-28	Fenofibrate dosage forms
CN101296894A	2006-10-27	Novel method for preparing quaternary acid and ammonium salts
EP1621200A1	2004-07-26	Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate
EP1591114A1	2004-03-12	Use of metformin and orlistat for the treatment or prevention of obesity
IES20040043A2	2004-01-23	Granulates comprising metformin and a fibrate, pharmaceutical compositions containing such granulates, and processes for preparing said granulates and said composition
EP1559419A1	2004-01-23	Pharmaceutical formulations comprising metformin and a fibrate, and processes for their obtention
EP1510208A1	2003-08-22	Pharmaceutical composition comprising a combination of metformin and statin
US2005276974A1	2003-05-23	Nanoparticulate fibrate formulations
EP1457206A1	2003-03-13	Combined use of a fibrate and orlistat for the treatment of obesity
EP1424070A1	2002-11-28	Combination of a PPAR alpha agonist and metformin for decreasing the serum triglycerides
WO0234259A1	2001-10-23	Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
AU2002221765B2	2001-10-23	Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction